Effect of the anticomplementary agent, K-76 monocarboxylic acid, on experimental immune complex glomerulonephritis in rats.
We examined the effect of the anticomplementary agent K-76 monocarboxylic acid (K-76COOH), which is known to inhibit C5 activity, on immune complex glomerulonephritis in rats. Bovine serum albumin (BSA) nephritis was induced in rats by subcutaneous immunization and daily intravenous administration of BSA. K-76COOH (30 mg/kg) was administered intraperitoneally twice daily for 4 weeks. It was shown that K-76COOH would significantly reduce the development of proteinuria in the early stage of BSA nephritis, but it failed to suppress proteinuria in the late stage. There was no significant difference in glomerular changes between treated animals and non-treated controls. These findings suggest that C5, and the terminal complement components may play a significant role in protein excretion in the early stage of immune complex glomerulonephritis.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000936:Antigen-Antibody Complex / Q000276:immunology*; D003182:Complement C5 / Q000032:analysis / Q000037:antagonists & inhibitors*; D003169:Complement Inactivator Proteins / Q000494:pharmacology*; D005921:Glomerulonephritis / Q000276:immunology* / Q000473:pathology; D007678:Kidney Glomerulus / Q000473:pathology; D008297:Male; D011507:Proteinuria / Q000276:immunology; D051381:Rats; D011918:Rats, Inbred SHR; D012717:Sesquiterpenes / Q000494:pharmacology*; D013997:Time Factors
D000888:Antibodies, Anti-Idiotypic; D000936:Antigen-Antibody Complex; D003182:Complement C5; D003169:Complement Inactivator Proteins; D012717:Sesquiterpenes; C038797:K 76 carboxylic acid